BWP
AXDX

BSW Wealth Partners’s Accelerate Diagnostics AXDX Stock Holding History

BSW Wealth Partners’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,171
Closed -$190K – 64
2015
Q3 		$190K Sell
1,171
-400
-25% -$86.6K 0.11% 58
2015
Q2 		$406K Sell
1,571
-600
-28% -$143K 0.26% 35
2015
Q1 		$489K Sell
2,171
-100
-4% -$20.9K 0.31% 33
2014
Q4 		$436K Sell
2,271
-500
-18% -$107K 0.35% 34
2014
Q3 		$595K Sell
2,771
-100
-3% -$19.4K 0.47% 27
2014
Q2 		$747K Sell
2,871
-1,100
-28% -$240K 0.59% 20
2014
Q1 		$866K Sell
3,971
-900
-18% -$133K 0.7% 16
2013
Q4 		$594K Buy
4,871
+321
+7% +$42.9K 0.47% 26
2013
Q3 		$610K Buy
+4,550
New +$406K 0.53% 23

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
MGM
Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BSW Wealth Partners's AXDX Position: Q4 2015 in Review

BSW Wealth Partners sold out of Accelerate Diagnostics (AXDX) in Q4 2015, closing a stake of 1,171 shares — an estimated $190K sold.

BSW Wealth Partners first reported a position in AXDX in Q3 2013 and held it in 9 quarters. The position peaked at $866K in Q1 2014. 97 funds tracked by Wall St. Rank hold AXDX as of Q4 2015.

  • BSW Wealth Partners reported no remaining Accelerate Diagnostics position as of Q4 2015 after selling out during the quarter.
  • BSW Wealth Partners sold 1,171 Accelerate Diagnostics shares in Q4 2015, an estimated $190K.
  • BSW Wealth Partners first reported a position in Accelerate Diagnostics in Q3 2013 and held it in 9 quarters.
  • BSW Wealth Partners's Accelerate Diagnostics position peaked at $866K in Q1 2014.
  • 97 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2015.

Based on BSW Wealth Partners's 13F filing for Q4 2015, filed 12 Feb 2016.